BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21512844)

  • 1. Prognostic significance of HLA class I expressing in gastric carcinoma defined by monoclonal anti-pan HLA class I antibody, EMR8-5.
    Lee HW; Min SK; Ju YS; Sung J; Lim MS; Yang DH; Lee BH
    J Gastrointest Surg; 2011 Aug; 15(8):1336-43. PubMed ID: 21512844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of HLA class I heavy chain expression in patients with gastric cancer.
    Ueda Y; Ishikawa K; Shiraishi N; Yokoyama S; Kitano S
    J Surg Oncol; 2008 Apr; 97(5):451-5. PubMed ID: 18247377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma.
    Nada OH; Ahmed NS; Abou Gabal HH
    Diagn Pathol; 2014 Mar; 9():72. PubMed ID: 24667142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of HLA class I expression in patients with colorectal cancer.
    Iwayama Y; Tsuruma T; Mizuguchi T; Furuhata T; Toyota N; Matsumura M; Torigoe T; Sato N; Hirata K
    World J Surg Oncol; 2015 Feb; 13():36. PubMed ID: 25889416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the downregulation of HLA class I antigen and clinicopathological significance in gastric cancer.
    Shen YQ; Zhang JQ; Miao FQ; Zhang JM; Jiang Q; Chen H; Shan XN; Xie W
    World J Gastroenterol; 2005 Jun; 11(23):3628-31. PubMed ID: 15962390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
    Kikuchi E; Yamazaki K; Torigoe T; Cho Y; Miyamoto M; Oizumi S; Hommura F; Dosaka-Akita H; Nishimura M
    Cancer Sci; 2007 Sep; 98(9):1424-30. PubMed ID: 17645781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of MHC class I expression and lymph node metastasis of gastric carcinoma.
    Yoshii M; Tanaka H; Ohira M; Muguruma K; Sakurai K; Kubo N; Yashiro M; Sawada T; Hirakawa K
    Hepatogastroenterology; 2013 May; 60(123):611-5. PubMed ID: 23108078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5.
    Tsukahara T; Kawaguchi S; Torigoe T; Asanuma H; Nakazawa E; Shimozawa K; Nabeta Y; Kimura S; Kaya M; Nagoya S; Wada T; Yamashita T; Sato N
    Cancer Sci; 2006 Dec; 97(12):1374-80. PubMed ID: 16995877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
    Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
    Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a monoclonal anti-pan HLA class I antibody suitable for immunostaining of formalin-fixed tissue: unusually high frequency of down-regulation in breast cancer tissues.
    Torigoe T; Asanuma H; Nakazawa E; Tamura Y; Hirohashi Y; Yamamoto E; Kanaseki T; Hasegawa T; Sato N
    Pathol Int; 2012 May; 62(5):303-8. PubMed ID: 22524657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis.
    Bandoh N; Ogino T; Katayama A; Takahara M; Katada A; Hayashi T; Harabuchi Y
    Oncol Rep; 2010 Apr; 23(4):933-9. PubMed ID: 20204276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Yuan J; Liu S; Yu Q; Lin Y; Bi Y; Wang Y; An R
    Acta Histochem; 2013 Jun; 115(5):470-4. PubMed ID: 23245688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical-pathological implication of human leukocyte antigen-F-positive gastric adenocarcinoma.
    Ishigami S; Arigami T; Setoyama T; Okumura H; Sasaki K; Uchikado Y; Kurahara H; Kijima Y; Nishizono Y; Nakajo A; Natsugoe S
    J Surg Res; 2013 Oct; 184(2):802-6. PubMed ID: 23706560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma.
    Mizukami Y; Kono K; Maruyama T; Watanabe M; Kawaguchi Y; Kamimura K; Fujii H
    Br J Cancer; 2008 Nov; 99(9):1462-7. PubMed ID: 18841157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
    Gao XH; Yang XQ; Wang BC; Liu SP; Wang FB
    Asian Pac J Cancer Prev; 2013; 14(9):5055-60. PubMed ID: 24175775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
    Qifeng S; Bo C; Xingtao J; Chuanliang P; Xiaogang Z
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):808-14. PubMed ID: 21335133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
    Vitale M; Pelusi G; Taroni B; Gobbi G; Micheloni C; Rezzani R; Donato F; Wang X; Ferrone S
    Clin Cancer Res; 2005 Jan; 11(1):67-72. PubMed ID: 15671529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 22 overexpression is associated with the progression and prognosis in gastric cancer.
    Li XS; Xu Q; Fu XY; Luo WS
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1305-13. PubMed ID: 24804817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implication of HLA class I expression in breast cancer.
    Kaneko K; Ishigami S; Kijima Y; Funasako Y; Hirata M; Okumura H; Shinchi H; Koriyama C; Ueno S; Yoshinaka H; Natsugoe S
    BMC Cancer; 2011 Oct; 11():454. PubMed ID: 22014037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.